This OEMAC position statement addresses the implications of cannabis use for individuals in safety-sensitive and decision-critical occupations. It aims to guide workplace safety policy and occupational health decisions amid growing cannabis use and legalization in Canada.
The statement is based on a comprehensive review of national and international literature, policy statements, and clinical guidelines from bodies such as OEMAC, and the Canadian Society of Addiction Medicine. It synthesizes evidence from peer-reviewed studies on cannabis pharmacology, patterns of impairment, workplace risk, and occupational medicine. The review considered diverse aspects of cannabis use, including THC concentration, consumption methods, frequency of use, individual variability, and co-use with other substances.
Cannabis can impair cognitive and motor function through intoxication, residual effects, withdrawal, and chronic use, often beyond the immediate period of consumption. The variability in individual responses and cannabis products complicates detection and risk assessment. Most studies don’t reflect real-world use, limiting their relevance. Given these uncertainties, a precautionary, risk-mitigation approach is justified for safety-sensitive and decision-critical work.
If you or someone you know is struggling with addiction or mental health issues, resources and services are available. The following helplines offer 27/4 confidential support in Alberta:
Health Link 811
Addiction Helpline 1-866-332-2322
Mental Health Helpline 1-877-303-2642
To learn more about Youth Addiction and Mental Health resources, please visit: https://myhealth.alberta.ca/HealthTopics/youth-addiction-mental-health